Tansey Plasma Meso Scale Discovery - Aligning Science Across Parkinson's

Research Community
Research Community

ASAP supports three programs and serves as a member of multiple consortia to advance research for the benefit of the global Parkinson’s disease community.
Explore
Highlights
Highlights

ASAP shares the impact that our initiative, network, and supported programs have had on providing new insights into Parkinson’s disease. Discover news, interviews, awards, and annual impact.
Explore
Open Science
Open Science

ASAP is dedicated to facilitating a research environment where meaningful collaboration, research-enabling resources, and data sharing provides the answers we need to understand, diagnose, and treat Parkinson’s disease. Discover our open science philosophy.
Explore
Tools & Resources
Tools & Resources

ASAP is committed to developing and openly sharing research outputs, including data, code, protocols, and key lab materials, to help the scientific community build upon existing work.
Explore

Description

Duplicates of plasma from individuals living with Parkinson's disease (PD), inflammatory bowel disease (IBD), or neurologically healthy controls (NHC) (25ul) were diluted 1:1 and used to quantify chemokine and cytokines via U-PLEX custom pro-inflammatory human panel (Eotaxin, Eotaxin-3, IFN-γ, IL-1β, IL-6, IL-8, CCL22 (MDC), TNF-α (MSD#; K15067M-1) and R-PLEX human ferritin (MSD#; F21ADA-3) on the Quickplex MSD instrument, according to the manufacturer’s protocol.

Identifier (DOI)

10.5281/zenodo.17652663

Tags

Human

Team

Team Liddle

Program

Collaborative Research Network

Theme

Circuitry and Brain-Body Interactions

Meet the Authors

Mackenzie Bolen

Key Personnel: Team Liddle,

University of Florida
Malú Tansey, PhD

Co-PI (Core Leadership): Team Liddle,

University of Florida